Pharmaceutical and chemical giant Bayer is committed to intensifying its research in China to make "the world's factory" a hub for innovation.

Johannes M. Dietsch, president of Bayer Greater China Group, said the German company is investing heavily in R&D to provide innovative goods that can meet China's needs.

"With innovative products that are designed to address core needs in China, for example urbanization, or the aging population, or sustainable farming, we believe that we have a really strong product portfolio in place that can capture the opportunities in China", he said at the Shanghai Science and Technology Museum on Wednesday, as he opened the local leg of a major exhibition to mark the 150th anniversary of Bayer.